Telomere dysfunction provokes regional amplification and deletion in cancer genomes
Open accessThe DOI matches its Crossref record; 55 of the 57 references it cites were found in a registry or an index.
Abstract
Telomere dysfunction and associated fusion-breakage in the mouse encourages epithelial carcinogenesis and a more humanized genomic profile that includes nonreciprocal translocations (NRTs). Here, array comparative genomic hybridization was used to determine the pathogenic significance of NRTs and to determine whether telomere dysfunction also drives amplifications and deletions of cancer-relevant loci. Compared to tumors arising in mice with intact telomeres, tumors with telomere dysfunction possessed higher levels of genomic instability and showed numerous amplifications and deletions in regions syntenic to human cancer hotspots. These observations suggest that telomere-based crisis provides a mechanism of chromosomal instability, including regional amplifications and deletions, that drives carcinogenesis. This model provides a platform for discovery of genes responsible for the major cancers affecting aged humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although enabling cellular growth and survival and masking degenerative phenotypes, these mTerc -/ -p53 mutant mice experience a dramatic increase in cancer incidence, shift in tumor spectrum toward epithelial cancers, and accumulation of marked chromosomal aberrations targeting cancerrelevant loci for amplification and deletion (4-6).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [6]
In the citing paper
“Specifically, p53 deficiency results in nearcomplete rescue of adverse cellular consequences associated with telomere dysfunction, including cellular growth arrest and apoptosis, progressive organ system atrophy, and physiological compromise.”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [6]
In the citing paper
“This may be because of an intact p53 checkpoint that eliminates genomically unstable cells and/or the emergence of ALT, which is expected to reduce the number of would-be cancer cells experiencing the breakage-fusion-bridge process and accumulation of regional amplifications and deletions (6).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [6]
In the citing paper
“G5/G6 TERCÀ/À p53À/À (or p53þ/À) mice showed significant acceleration of the rate of tumor formation and altered the spectrum of tumor types (104).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [104]
In the citing paper
“In contrast to the typical tumor spectrum of p53þ/À mice with intact telomeres, G5/G6 TERCÀ/À p53þ/À mice developed epithelial cancers, particularly those of the skin, breast and gastrointestinal tract.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [104]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Cell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,039
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
The Age Distribution of Cancer and a Multi-stage Theory of Carcinogenesis
Armitage, P., & Doll, R. (1954) · British Journal of Cancer · doi:10.1038/bjc.1954.1 · Cited by 1,549
The age distribution of cancer and a multi-stage theory of carcinogenesis
Armitage, P., & Doll, R. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602297 · Cited by 1,285
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
Artandi, S. E., Chang, S., Lee, S.-L., Alson, S., Gottlieb, G. J., Chin, L., & DePinho, R. A. (2000) · Nature · doi:10.1038/35020592 · Cited by 1,085
Self-citationChin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979 · cited 1×
“The analysis of human cultured cells in crisis (Counter et al., 1992), evolving human colorectal cancers (Hastie et al., 1990; Chadeneau et al., 1995; Rudolph et al., 2001), engineered telomeric double strand breaks in mouse embryonic stem cells (Lo et al., 2002), and tumors arising in mice with telomere dysfunction (…”
BackgroundSelf-citationDePinho, R. A. (2000) · Nature · doi:10.1038/35041694 · Cited by 951 · cited 1×
“In addition, there are significant species differences in tumor spectrum associated with advancing age: aged humans develop predominantly epithelial cancers, while mice sustain a high incidence of lymphomas and soft tissue sarcoma throughout life ( DePinho, 2000 ).”
BackgroundSelf-citationDevelopmental and tissue-specific regulation of mouse telomerase and telomere length.
Prowse, K. R., & Greider, C. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4818 · Cited by 690
Hypervariable ultra-long telomeres in mice
Kipling, D., & Cooke, H. J. (1990) · Nature · doi:10.1038/347400a0 · Cited by 614 · cited 1×
“Unlike humans, the laboratory mouse, Mus musculus, possesses long telomeres and shows ready activation of telomerase in the setting of neoplasia ( Kipling and Cooke, 1990; Broccoli et al., 1996); thus, telomere-based crisis does not”
Background
Research works printed but not linked: 1
- Shen, 2000, Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma, Cancer Res., 60, 3884
Cited by
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
“End-to-end chromosome fusions are a cytogenetic hallmark of telomere loss (Artandi et al., 2000; Gisselsson et al., 2001; O’Hagan et al., 2002), and the two centromeres of such dicentric chromosomes are pulled to opposite daughter”
BackgroundInfluentialHepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1934 · Cited by 1,979
Self-citationThe RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
“…experience telomere dysfunction, leading to chromosomal end-end joining and fusion-bridge-breakage cycles that trigger the aneuploidy observed in most carcinomas (Hanahan and Weinberg, 2000; Sherr and DePinho, 2000; Wright and Shay, 2000; Hahn and Weinberg, 2002; O’Hagan et al., 2002 [this issue]).”
BackgroundGenetics and biology of pancreatic ductal adenocarcinoma
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,577
Self-citationThe Life History of 21 Breast Cancers
Nik-Zainal, S., Van Loo, P., Wedge, D. C., Alexandrov, L. B., Greenman, C. D., Lau, K. W., Raine, K., Jones, D., Marshall, J., Ramakrishna, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.023 · Cited by 1,443
“Carcinogenic exposures and DNA repair defects can lead to sustained elevations in mutation rate; telomere attrition and chromothripsis can drive massive genomic rearrangement in catastrophic bursts (Bignell et al., 2007; Campbell et al., 2010; O’Hagan et al., 2002; Stephens et al., 2011).”
Metadata
- Authors
- O'Hagan, R. C., Chang, S., Maser, R. S., Mohan, R., Artandi, S. E., Chin, L., & DePinho, R. A.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Stanford University (US)
- Corresponding author
- DePinho, Ronald A
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2002-08
- Volume
- 2
- Issue
- 2
- Pages
- 149-155
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W1969649126
- Cited by
- 246
- References
- 57
- Citations by year
- 2025: 3 · 2023: 5 · 2022: 6 · 2021: 9 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 8 · 2016: 7 · 2015: 6 · 2014: 5 · 2013: 12 · 2012: 20
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4003 d)
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (1KO8AG01019-01, K08AG001019)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Chromosomal and Genetic Variations
- Keywords
- telomere dysfunction, telomere crisis, non-reciprocal translocation, chromosomal instability, gene amplification, gene deletion, cancer hotspots, epithelial carcinogenesis, mouse tumor model, genomic instability
- MeSH terms
- Animals, Chromosome Aberrations, DNA, Neoplasm, Gene Amplification, Humans, Neoplasms, RNA, Genes, p53, Telomere, Genome, Gene Deletion, Telomerase, Synteny, Chromosomes, Mammalian, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Telomere dysfunction provokes regional amplification and deletion in cancer genomes. https://app.cochat.ai/papers/10.1016/s1535-6108(02)00094-6
- The paper
- O'Hagan, R. C., Chang, S., Maser, R. S., Mohan, R., Artandi, S. E., Chin, L., & DePinho, R. A. (2002). Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell. https://doi.org/10.1016/s1535-6108(02)00094-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.